Literature DB >> 28846112

Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis.

J-L Park1,2, Y-S Lee3, M-J Song4, S-H Hong3, J-H Ahn5, E-H Seo1,2, S-P Shin6, S-J Lee6, B H Johnson7, M R Stampfer8, H-P Kim4,9,10, S-Y Kim1,2, Y S Lee7,11.   

Abstract

RNA polymerase III (Pol III) transcribes medium-sized non-coding RNAs (collectively termed Pol III genes). Emerging diverse roles of Pol III genes suggest that individual Pol III genes are exquisitely regulated by transcription and epigenetic factors. Here we report global Pol III expression/methylation profiles and molecular mechanisms of Pol III regulation that have not been as extensively studied, using nc886 as a representative Pol III gene. In a human mammary epithelial cell system that recapitulates early breast tumorigenesis, the fraction of actively transcribed Pol III genes increases reaching a plateau during immortalization. Hyper-methylation of Pol III genes inhibits Pol III binding to DNA via inducing repressed chromatin and is a determinant for the Pol III repertoire. When Pol III genes are hypo-methylated, MYC amplifies their transcription, regardless of its recognition DNA motif. Thus, Pol III expression during tumorigenesis is delineated by methylation and magnified by MYC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28846112     DOI: 10.1038/onc.2017.285

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Are We Studying Non-Coding RNAs Correctly? Lessons from nc886.

Authors:  Yong Sun Lee
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.

Authors:  Ji-Hye Ahn; Hyun-Sung Lee; Ju-Seog Lee; Yeon-Su Lee; Jong-Lyul Park; Seon-Young Kim; Jung-Ah Hwang; Nawapol Kunkeaw; Sung Yun Jung; Tae Jin Kim; Kwang-Soo Lee; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Jung-Hye Choi; Yong Sun Lee
Journal:  Nat Commun       Date:  2018-03-21       Impact factor: 14.919

Review 3.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

Review 4.  BC200 (BCYRN1) - The shortest, long, non-coding RNA associated with cancer.

Authors:  J Samson; S Cronin; K Dean
Journal:  Noncoding RNA Res       Date:  2018-05-22

5.  Effects on prostate cancer cells of targeting RNA polymerase III.

Authors:  John L Petrie; Caroline Swan; Richard M Ingram; Fiona M Frame; Anne T Collins; Hélène Dumay-Odelot; Martin Teichmann; Norman J Maitland; Robert J White
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

6.  Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound.

Authors:  Nawapol Kunkeaw; Yeon-Su Lee; Wonkyun Ronny Im; Jiyoung Joan Jang; Min-Ji Song; Bobae Yang; Jong-Lyul Park; Seon-Young Kim; Yongsuk Ku; Yoosik Kim; Sangmin Kang; Hye-Ram Jo; Jae-Hoon Jeong; Hyun-Sung Lee; Ju-Seog Lee; Hyoung-Pyo Kim; Betty H Johnson; In-Hoo Kim; Yong Sun Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-04       Impact factor: 11.205

Review 7.  Vault RNAs: hidden gems in RNA and protein regulation.

Authors:  Jens Claus Hahne; Andrea Lampis; Nicola Valeri
Journal:  Cell Mol Life Sci       Date:  2020-10-15       Impact factor: 9.261

8.  Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.

Authors:  Dritan Liko; Louise Mitchell; Kirsteen J Campbell; Rachel A Ridgway; Carolyn Jones; Kate Dudek; Ayala King; Sheila Bryson; David Stevenson; Karen Blyth; Douglas Strathdee; Jennifer P Morton; Thomas G Bird; John R P Knight; Anne E Willis; Owen J Sansom
Journal:  Cell Death Differ       Date:  2019-03-11       Impact factor: 12.067

9.  A Regulatory Noncoding RNA, nc886, Suppresses Esophageal Cancer by Inhibiting the AKT Pathway and Cell Cycle Progression.

Authors:  Wonkyun Ronny Im; Hyun-Sung Lee; Yeon-Su Lee; Ju-Seog Lee; Hee-Jin Jang; Seon-Young Kim; Jong-Lyul Park; Yeontaek Lee; Moon Soo Kim; Jong Mog Lee; In-Hoo Kim; Sung Ho Jeon; Yong Sun Lee
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

10.  A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.

Authors:  Stephanie Cabarcas-Petroski; Patricio I Meneses; Laura Schramm
Journal:  BMC Cancer       Date:  2020-11-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.